DOI QR코드

DOI QR Code

Folate Pathway Gene MTHFR C677T Polymorphism and Risk of Lung Cancer in Asian Populations

  • Rai, Vandana (Department of Biotechnology, Human Molecular Laboratory, VBS Purvanchal University)
  • Published : 2014.11.28

Abstract

Background: Previous studies concerning the association between the 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism with lung cancer in Asian populations have provided inconclusive findings. Aim: A meta-analysis was performed to investigate a more reliable association between MTHFR C677T polymorphism and lung cancer in Asians. Materials and Methods: A comprehensive search was conducted to identify all case-control studies of MTHFR polymorphisms and lung cancer in Asia, using odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of any association. Results: Meta-analysis results suggested that the MTHFR C677T polymorphism contributed to an increased lung cancer risk in Asian populations (for T vs C: OR=1.11, 95%CI=1.0-1.23; for CT vs CC: OR= 1.1, 95%CI= 0.95-1.2 ; for TT+CT vs CC: OR=1.13, 95%CI=1.0-1.30; for TT vs CC: OR=1.25, 95%CI=1.01-1.30; for TT vs CT+CC: OR=1.16, 95%CI=1.0-1.36). Conclusions: MTHFR C677T polymorphism is significantly associated with lung cancer in Asians.

References

  1. Bailey LB, Gregory JF (1999). Folate metabolism and requirements. J Nutrit, 129, 779-82.
  2. Bax L, Yu LM, Ikeda N, et al (2006). Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol, 6, 50. https://doi.org/10.1186/1471-2288-6-50
  3. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  4. Blount BC, Mack MM, Wehr CM, et al (1997). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA, 94, 3290-5. https://doi.org/10.1073/pnas.94.7.3290
  5. Boccia S, Boffetta P, Brennan P, et al (2009). Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett, 273, 55-61. https://doi.org/10.1016/j.canlet.2008.07.026
  6. Botto LD, Yang Q (2000). 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol, 151, 862-77. https://doi.org/10.1093/oxfordjournals.aje.a010290
  7. Cheng Z, Wang W, Song YN, et al (2011). Investigation of the relationship between C677T polymorphisms of methylenetetra-hydrofolate reductase and lung cancer risk. Chin J Tuberc Respir Dis, 34, 57 58.
  8. Cui LH, Shin MH, Kim HN, et al (2011a). Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population. BMC Med Genet, 12, 28.
  9. Cui LH, Yu Z, Zhang TT, et al (2011b). Influence of polymorphisms in MTHFR 677 C/T, TYMS 3R/2R and MTR 2756 A/G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC. Pharmacogenomics, 12, 797-808. https://doi.org/10.2217/pgs.11.27
  10. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
  11. Duthie SJ (1999). Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull, 55, 578-92. https://doi.org/10.1258/0007142991902646
  12. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  13. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  14. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methelenetetrahydrofolate reductase. Nat Genet, 10, 111-3 https://doi.org/10.1038/ng0595-111
  15. Guan P, Huang D, Yin Z, et al (2011). Association of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls. Asian Pac J Cancer Prev, 12, 1067-72.
  16. Goyette P, Sumner JS, Milos R, et al (1994). Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet, 7, 551.
  17. Goyette P, Pai A, Milos R, et al (1998). Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome, 9, 652-6. https://doi.org/10.1007/s003359900838
  18. Hegele RA, Tully C, Young TK, Connelly PW (1997). V677 mutation of methylenetetrahydrofolate reductases and cardiovascular disease in Canadian Inuit. Lancet, 349, 1221-2.
  19. Hubner RA, Houlston RS (2007). MTHFR C677T and colorectal cancer risk: a meta analysis of 25 populations. Int J Cancer, 120, 1027-35.
  20. Hung RJ, Hashibe M, McKay J, et al (2007). Folate-related genes and the risk of tobacco-related cancers. Carcinogenesis, 28, 1334-40. https://doi.org/10.1093/carcin/bgm067
  21. Jeng YL, Wu MH, Huang HB, et al (2003). The methylenetetrahydrofolate reductase 677C$\rightarrow$ T polymorphism and lung cancer risk in a Chinese population. Anticancer Res, 23, 5149-52.
  22. Jin C, Zhang YH, Peng MF, et al (2007). Study of the relationship between C677T, A1298C gene polymorphisms of methylenetetrahydrofolate reductase and lung cancer. Chin Clin Oncol, 12, 671-5.
  23. Kim Y I, Pogribny I P, Basnakian AG, et al (1997). Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr, 65, 46-52.
  24. Kim YI (1999). Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem, 10, 66-88. https://doi.org/10.1016/S0955-2863(98)00074-6
  25. Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y (2011). Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case control study in a Japanese population. BMC Cancer, 11, 459. https://doi.org/10.1186/1471-2407-11-459
  26. Liang H, Yan Y, Li T, et al (2013). Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies. Tumor Biol, DOI 10.1007/s13277-013-1234-9.
  27. Liao SG, Liu L, Zhang YY, et al (2012). SULT1A1 Arg213His polymorphism and lung cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 579-83. https://doi.org/10.7314/APJCP.2012.13.2.579
  28. Liu CS, Tsai CW, Hsia TEC (2009). Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomic, 6, 325-9.
  29. Liu H, Jin G, Wang H, et al (2008). Association of polymorphisms in one-carbon metabolizing genes and lung cancer risk: a case-control study in Chinese population. Lung Cancer, 61, 21-9. https://doi.org/10.1016/j.lungcan.2007.12.001
  30. Liu ZB, Wang LP, Shu J, Jin C, Lou ZX (2013). Methylenetetrahydrofolate reductase 677TT genotype might be associated with an increased lung cancer risk in Asians. Gene, 515, 214-9. https://doi.org/10.1016/j.gene.2012.11.036
  31. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
  32. Mei Q, Zhou D, Gao J, et al (2012). The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis. BMC Cancer, 12, 467-76. https://doi.org/10.1186/1471-2407-12-467
  33. Pan F, Tian J, Pan Y, et al (2011). Lack of association of the cyclooxygenase 8473 T>C polymorphism with lung cancer: evidence from 9841 subjects. Asian Pac J Cancer Prev, 12, 1941-5.
  34. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  35. Pepe G, Camacho Vanegas O, Giusti B, et al (1998). Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet, 63, 917-20. https://doi.org/10.1086/302015
  36. Rai V, Yadav U, Kumar P, Yadav SK (2010). Methyleletetrahydrofolate reductase polymorphism (C677T) in Muslim population of Eastern Uttar Pradesh, India. IJMS, 64, 219-23.
  37. Rai V, Yadav U, Kumar P (2012). Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in eastern Uttar Pradesh. Indian J Human Genetics, 18, 43-6. https://doi.org/10.4103/0971-6866.96645
  38. Rai V (2011). Evaluation of methylenetetrahydrofolate reductase gene variant (C677T) as risk factor for bipolar disorder. Cell Mol Biol, 57, 1558-66.
  39. Rai V (2014). Methylenetetrahydrofolate reductase gene A1298C polymorphism and susceptibility to recurrent pregnancy loss: a meta-analysis. Cell Mol Biol, 60, 27-34.
  40. Robien K, Ulrich CM (2003). 5,10- Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemio, 157, 571-82. https://doi.org/10.1093/aje/kwg024
  41. Sharp L, Little J (2004). Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol, 159, 423-43. https://doi.org/10.1093/aje/kwh066
  42. Shen M, Rothman N, Berndt SI, et al (2005). Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer, 49, 299-309. https://doi.org/10.1016/j.lungcan.2005.04.002
  43. Stern LL, Mason JB, Selhub J, Choi SW (2000). Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev, 9, 849-53.
  44. Suzuki T, Matsuo K, Hiraki A, et al (2007). Impact of onecarbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case-control study. Carcinogenesis, 28, 1718-25. https://doi.org/10.1093/carcin/bgm104
  45. Tu YL, Wang SB, Tan XL (2012). MTHFR Gene polymorphisms are not involved in pancreatic cancer risk: A meta-analysis. Asian Pac J Cancer Prev, 13, 4627-30. https://doi.org/10.7314/APJCP.2012.13.9.4627
  46. Weisberg I, Tran P, Christensen B, et al (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab, 64, 169-72. https://doi.org/10.1006/mgme.1998.2714
  47. Whitehead A (2002). Meta-analysis of controlled clinical trials. Wiley, Chichester, UK.
  48. Yadav U, Kumar P, Rai V (2011). Docking study of MTHFR with FAD by Hex. J Comput Intell Bioinformatics, 4, 171-8.
  49. Yadav U, Kumar P, Yadav SK, Mishra OP, Rai V (2014). Polymorphisms in folate metabolism genes as maternal risk factor for Neural Tube Defects: an updated meta-analysis. Metabolic Brain Disease.
  50. Yang XX, Li FX, Yi JP, et al (2010). Polymorphisms of the methylenetetrahydrofolate reductase C677T and risk of gastric cancer, colon cancer and lung cancer. Guangdong Med J, 31, 2375-8.
  51. Yao QF, Chen X, Xue JR, et al (2010). Relationship of polymorphisms of MTHFR gene hypermethylation of tumor suppressor gene in lung cancer. Cancer Res Prev Treat, 37, 531-4.
  52. Zhang XM, Miao XP, Tan W, et al (2005). Association between genetic polymorphisms in methylentetrahydrofolate reductase and risk of lung cancer. Acta Academiae Medicinae Sinicae, 27, 700-3.
  53. Zintzaras E, Hadjigeorgiou GM (2005). The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis. J Hum Genet, 50, 560-6. https://doi.org/10.1007/s10038-005-0295-z
  54. Zintzaras E, Ioannidis JP (2005). Heterogeneity testing in meta analysis of genome searches. Genet Epidemiol, 28, 123-37. https://doi.org/10.1002/gepi.20048
  55. Zintzaras E (2007). Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis. J Human Genetics, 52, 943-53. https://doi.org/10.1007/s10038-007-0202-x

Cited by

  1. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4525
  2. Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3101
  3. Evaluation of the MTHFR C677T Polymorphism as a Risk Factor for Colorectal Cancer in Asian Populations vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8093
  4. Thymidylate Synthase Polymorphisms and Risk of Lung Cancer among the Jordanian Population: a Case Control Study vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8287
  5. Gene Polymorphisms in Morbidly Obese Patients vol.2016, pp.1875-8630, 2016, https://doi.org/10.1155/2016/7853424
  6. Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Male Infertility in Asian Population vol.32, pp.3, 2017, https://doi.org/10.1007/s12291-017-0640-y
  7. Folate and Its Impact on Cancer Risk vol.7, pp.3, 2018, https://doi.org/10.1007/s13668-018-0237-y